Tyr Pharma has been able to make significant progress developing its lead clinical drug for the treatment of patients with pulmonary sarcoidosis. See why ATYR stock is a Buy.

Fidus Investment easily covered its base dividend with adjusted net investment income in Q2. Read why I think FDUS stock is a ...

Energy Fuels is increasing uranium production to 1.1-1.4mm pounds/year by end-2024. Read why I am rerating UUUU shares with a ...

Broadcom's stock skidded 10% on Friday despite strong Q3 earnings and a beat on the top/bottom line. See why I upgrade AVGO ...

Today's European markets saw declines, with Stoxx 600 down 0.50%. Bond yields also dropped, including U.S.

Modine has shown its increasing efficiency through two very important measures, ROIC and ROCE. These capital efficiency ...